Endo’s Generics Face Competitive Pressures
Company Sees Predicted Decline In Overall & Generics Revenues
After seeing increased demand because of COVID-19 in the first quarter of 2020, Endo’s generics segment has seen a predicted decrease in revenues in the second quarter. Furthermore, the company has also predicted an unfavorable impact due to competitive pressures for 2020 as a whole.
